Wockhardt Limited (NSE:WOCKPHARMA)
India · Delayed Price · Currency is INR 2,179.20
-41.40 (-1.86%)
Sep 11, 2026, 3:30 PM IST
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 354.14 billion as of September 11, 2026. Its market cap has increased by 39.71% in one year.
Market Cap
354.14B
Enterprise Value
373.74B
Revenue
36.53B
Ranking
n/a
PE Ratio
86.53
Stock Price
2,179.20
ChartMarket Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 354.14B, an increase of 1,934.82%. That is a compound annual growth rate of 12.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 354.14B | 50.70% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 681.51B |
| Alkem Laboratories | 614.32B |
| Ipca Laboratories | 500.03B |
| Gland Pharma | 486.14B |
| Ajanta Pharma | 439.77B |
| Emcure Pharmaceuticals | 372.30B |
| Piramal Pharma | 282.46B |
| Eris Lifesciences | 187.98B |